0.00Open0.01Pre Close0 Volume459 Open Interest71.00Strike Price0.00Turnover3687.39%IV8.58%PremiumApr 25, 2025Expiry Date0.00Intrinsic Value100Multiplier-12DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0060Delta0.0033Gamma7765.00Leverage Ratio-36.6972Theta0.0000Rho-46.23Eff Leverage0.0000Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet